Scholar Rock Holding Co. (NASDAQ:SRRK) General Counsel Junlin Ho Sells 5,742 Shares

Scholar Rock Holding Co. (NASDAQ:SRRK) General Counsel Junlin Ho sold 5,742 shares of the firm’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $36.83, for a total value of $211,477.86. Following the transaction, the general counsel now directly owns 189,295 shares in the company, valued at $6,971,734.85. This trade represents a 2.94 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Junlin Ho also recently made the following trade(s):

• On Thursday, January 16th, Junlin Ho sold 9,039 shares of Scholar Rock stock. The shares were sold at an average price of $44.20, for a total value of $399,523.80.

Scholar Rock Stock Up 3.0 %

NASDAQ SRRK opened at $39.15 on Friday. The company has a debt-to-equity ratio of 0.63, a current ratio of 3.88 and a quick ratio of 3.88. Scholar Rock Holding Co. has a 1 year low of $6.76 and a 1 year high of $46.98. The business’s 50-day moving average is $41.89 and its 200 day moving average is $28.17.

Institutional Trading of Scholar Rock

Several institutional investors and hedge funds have recently bought and sold shares of SRRK. Creative Planning purchased a new stake in Scholar Rock in the third quarter worth about $115,000. E. Ohman J or Asset Management AB lifted its holdings in Scholar Rock by 32.6% in the third quarter. E. Ohman J or Asset Management AB now owns 122,000 shares of the company’s stock worth $977,000 after buying an additional 30,000 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its holdings in Scholar Rock by 21.6% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,895 shares of the company’s stock worth $25,000 after buying an additional 514 shares during the period. abrdn plc lifted its holdings in Scholar Rock by 28.2% in the third quarter. abrdn plc now owns 748,489 shares of the company’s stock worth $5,995,000 after buying an additional 164,715 shares during the period. Finally, China Universal Asset Management Co. Ltd. lifted its holdings in Scholar Rock by 64.3% in the third quarter. China Universal Asset Management Co. Ltd. now owns 15,393 shares of the company’s stock worth $123,000 after buying an additional 6,023 shares during the period. 91.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on SRRK. HC Wainwright raised their price objective on Scholar Rock from $40.00 to $50.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Truist Financial raised their price objective on Scholar Rock from $36.00 to $45.00 and gave the company a “buy” rating in a research note on Monday, November 25th. Finally, Wedbush reissued an “outperform” rating and issued a $47.00 target price on shares of Scholar Rock in a research note on Wednesday, January 29th. Six investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $40.43.

Scholar Rock Company Profile

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.